Sunday - October 26, 2025
Blood Test Guides Post-Surgical Immunotherapy for Muscle-Invasive Bladder Cancer
October 20, 2025
BOSTON, Massachusetts, Oct. 20 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release:

* * *

Blood Test Guides Post-Surgical Immunotherapy for Muscle-Invasive Bladder Cancer

*

The Dana-Farber-co-led phase 3 IMvigor011 trial results show that periodic ctDNA screening after surgery can help guide a decision to begin adjuvant immunotherapy.

Patients with muscle-invasive bladder cancer who test p . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products